AstraZeneca PLC
1343.50
25-April-25 10:24:53
15 minutes delayed
Stocks
+6.00
+0.45%
Today's range
1333.50 - 1360.00
ISIN
N/A
Source
Cboe
-
AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis
21 Dec 2023 19:47:36 By NASDAQ US Markets
-
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
21 Dec 2023 19:44:53 By MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 Dec 2023 03:30:35 By Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 Dec 2023 02:42:28 By NASDAQ US Markets
-
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
10 Dec 2023 22:22:28 By NASDAQ US Markets
-
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
10 Dec 2023 08:09:34 By NASDAQ US Markets
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 Dec 2023 06:46:15 By NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 Dec 2023 08:27:21 By NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 Dec 2023 07:12:31 By NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 Dec 2023 01:39:09 By NASDAQ US Markets